Lineage tracing follows the progeny of labeled cells through development. This technique identifies precursors of mature cell types in vivo and describes the cell fate restriction steps they undergo in temporal order. In the mouse pancreas, direct cell lineage tracing reveals that Pdx1-expressing progenitors in the early embryo give rise to all pancreatic cells. The progenitors for the mature pancreatic ducts separate from the endocrine/exocrine tissues before E12.5. Expression of Ngn3 and pancreatic polypeptide marks endocrine cell lineages during early embryogenesis, and these cells behave as transient progenitors rather than stem cells. In adults, Ngn3 is expressed within the endocrine islets, and the NGN31 cells seem to contribute to pancreatic islet renewal. These results indicate the stage at which each progenitor population is restricted to a particular fate and provide markers for isolating progenitors to study their growth, differentiation, and the genes necessary for their development. q
Lineage tracing as a tool for developmental studies
In lineage analysis, cells are labeled or marked so that one can identify their progeny later during development (Stern and Fraser, 2001 ). In the pancreas, lineage analysis provides positive identification of the progenitor cells that give rise to specific mature pancreatic cells, and the stage at which each set of progenitors is restricted to a particular cell fate. Identification of specific progenitor cells allows one to label and isolate these cells, and to study their growth, in vitro differentiation, and gene expression profile. These in vitro studies allow the exploration of the extracellular signals and the genetic programs controlling pancreatic cell maturation. Furthermore, identification of the various pancreatic progenitors, especially that of the embryonic endocrine islet, may provide starting material to produce islets for transplantation. The putative adult islet stem cell, if identified, would also allow the study of b-cell neogenesis, potentially an important therapy for diabetic patients (Berna et al., 2001) .
In this review, we first describe methodologies used to identify cell lineages. We then discuss the major known markers that define each set of pancreatic progenitors during embryogenesis, and the more limited data for adult cell renewal. Finally, we consider some unanswered issues, including the existence of the putative adult pancreatic stem cell, and discuss the possible plasticity observed in a number of stem cell populations to speculate on how already-restricted lineages can be induced to another fate.
Different methodologies for pancreatic cell lineage analysis
Cells have been labeled using at least two distinct approaches (Stern and Fraser, 2001) . A physical label such as dye or a replication-incompetent retrovirus can be directly injected into embryos to label cells within a tissue. This method marks cells indiscriminately, and in most tissues cannot label specific sub-populations (Cepko et al., 2000) . A sufficiently low dose of retrovirus, however, may introduce a single infection event that can be followed. In any case, the tissue is allowed to mature in vivo or in culture, and the cell types that become labeled reveal the lineage of the starting cells (Fishman and Melton, 2002) .
Another approach is to genetically mark progenitor cells using endogenous gene expression patterns. This method selectively labels cells that express a particular gene, thus revealing the fate of their progeny. There are several options for such experiments; (1) a tissue specific promoter driving Cre recombinase to irreversibly tag cells (Herrera, 2000; Jasinski et al., 2001; Kisanuki et al., 2001; Nagy and Mar, 2001) ; (2) a transgene driven by a specific promoter within different cell types (Alpert et al., 1988) ; (3) presence of endogenous proteins within different cell types (Teitelman et al., , 1993 Upchurch et al., 1994) ; (4) lineage ablation using gene-inactivation mutants or transgenic expression of cellular toxins (Herrera et al., 1994) . All four of these approaches have been used to follow pancreatic cell lineages.
2.1. Cre/LoxP can be used to irreversibly label cells Cells can be irreversibly marked using the Cre/LoxP system (Sanes, 1994; Sato et al., 2000) , thus permitting detection of progeny cells that no longer express the gene of interest. This system uses two transgenic mouse lines, a reporter and a deletor (Fig. 1) . The reporter transgene uses a promoter (promoter 1), which can be tissue specific (Herrera, 2000) or ubiquitous (Lobe et al., 1999; Mao et al., 1999) , to drive the expression of a reporter gene [such as human growth hormone (Herrera, 2000) , LacZ (Mao et al., 1999) , green fluorescent protein (GFP) (Mao et al., 2001) , or human alkaline phosphatase (Lobe et al., 1999) ]. The deletor line carries a transgene that uses a different tissue specific promoter (promoter 2) to drive the expression of Cre recombinase. In the absence of the Cre deletor transgene, a blocking sequence (multiple repeats of a polyadenylation signal, Sanes, 1994) upstream of the reporter coding sequence prevents expression of the reporter protein. However, two LoxP sites flanking the blocking sequence permit this block to be removed by Cre recombinase. Thus, in the double transgenic animals, the reporter gene will be expressed in cells following the excision event, thereby labeling all progeny derived from those precursors that express the deletor transgene.
A refinement of the Cre/LoxP system uses the CRE-ERe recombinase, a fusion between the catalytic domain of the CRE recombinase and the ligand-binding domain of a modified estrogen receptor (Danielian et al., 1998) . The conventional CRE recombinase activates the reporter transgene expression as soon as CRE protein is generated, and labeled cells accumulate throughout embryogenesis in any lineage where Cre has been expressed. The CRE-ERe protein requires an artificial ligand, tamoxifen, to catalyze LoxP mediated recombination (Danielian et al., 1998; Metzger et al., 1995) . Because tamoxifen is active within mouse embryos for less than 48 h, cells expressing Cre-ERe at a specific developmental stage can be selectively labeled by administration of tamoxifen during that stage. Thus, this type of recombinase can be used to follow the progeny of cells born at defined developmental stages, including postnatal growth and during regeneration (Danielian et al., 1998; Gu et al., 2002; Metzger et al., 1995) .
Lineage analysis based on simple transgenes
A simpler transgenic approach drives expression of a reporter gene, such as an easily detectable antigen, under the promoter of interest (Alpert et al., 1988) . The disadvantage of this approach is that any progeny of these cells which cease expression of the chosen protein cannot be followed. In addition, this method marks cells from the first time the promoter is activated, and as these cells accumulate during development it becomes impossible to distinguish new members of the population. Thus, one cannot distinguish the progeny of cells born during embryogenesis from those born in adults (Le Douarin, 1988) .
Endogenous gene expression cannot be regarded as a bona fide lineage tracer
Endogenous proteins have occasionally been used as line- Fig. 1 . Scheme used for direct cell lineage analysis. The reporter line uses promoter 1 (Pro.1, green line) to drive gene expression (R, yellow rectangle). Upstream of the reporter gene coding region is a blocking signal made of three repeat of a polyA signal (B, dark blue rectangle). Flanking the blocker signal are two LoxP sites (light blue triangle). Promoter 1 can be a tissue specific promoter (Herrera, 2000) or a ubiquitous promoter (Lobe et al., 1999; Mao et al., 1999) . In the deletor line, another tissue specific promoter (Pro. 2, black line) is used to drive the expression of Cre recombinase (black rectangle). When the two lines are crossed, CRE is expressed in the cells in which promoter 2 is active and deletes the blocker signal. This results in the expression of the reporter gene in cells that also express promoter 1. By studying reporter gene expression in different cell types in adults or during later development, all cell types derived from progenitors which express promoter 2 can be identified. The circles represent cells. The outer circle denotes the cytoplasmic membrane and the inner circle denotes the nuclear membrane. The different colors used in each large circle denote different cell types, the yellow coloration in cells represents reporter gene expression. age tracers, based on the assumption that the presence of a common protein molecule in two cells is evidence of derivation from a common progenitor. This assumption is fundamentally flawed. Gene expression is dynamic, the half-lifes of endogenous proteins vary, and patterns of cell death during embryogenesis are largely unappreciated (Le Douarin, 1988) . Thus, conclusions based upon this assumption may lead to conclusions that are vastly different from the underlying biology. For example, cells in the early pancreatic rudiment that co-express the hormones insulin and glucagon had been hypothesized to be progenitors of the mature insulin-secreting and glucagon-secreting endocrine cells (Teitelman et al., 1993) . Yet direct cell labeling demonstrated that these cells are not necessary for generation of mature endocrine cells, and in fact do not contribute appreciably to adult islets (Herrera, 2000) .
Lineage analysis based on cell ablation
Cell ablation leading to a lack of specific cell types can also indicate lineage relationships. This can be accomplished by gene inactivation (knockout) mutations, such as the Pdx1 knockout mouse, which has no mature pancreatic cells (Jonsson et al., 1994; Offield et al., 1996) . Alternatively, a tissue specific promoter can be used to drive expression of a cellular toxin, such as the Diphtheria Toxin A subunit, in transgenic animals. The Diphtheria Toxin A subunit kills cells via a cell-autonomous mechanism, and its expression in transgenic animals will eliminate the population of cells whose progenitors express that specific transgene (Herrera et al., 1994) . In either case, the absence of a particular cell type is taken as evidence that the chosen gene product labels precursors for the absent cell types. Cell ablation phenotypes, however, are not always an accurate source of lineage data, because some proteins can act non-cell autonomously. For example, this approach does not address whether the ablated cells themselves are the progenitors, or whether the presence of the ablated cells is necessary for a neighboring population to adopt the absent cell fate.
Anatomy, function, and diseases of the pancreas
The mammalian pancreas has three main tissue types: exocrine acini, ducts, and endocrine islets (Fig. 2) . The exocrine cells constitute about 85% of the pancreas and are organized into acini. These acini secret digestive enzymes that are emptied into the pancreatic duct, a branched network of variously sized tubules formed by epithelial duct cells. Ductal cells secrete bicarbonate and other electrolytes, which drain into the duodenum through the main duct along with the digestive enzymes (Githens, 1994) . The endocrine islets of Langerhans consist of a, b, d and PP cells that form discrete clusters within the acinarductal matrix. These cells secrete glucagon, insulin, somatostatin, and pancreatic polypeptide, respectively. Insulin and glucagon function together to regulate glucose metabolism. Somatostatin and pancreatic polypeptide regulate the secretion of other hormones and of exocrine enzymes (Adrian et al., 1978; Csaba and Dournaud, 2001; Roncoroni et al., 1983) .
Malfunction of the pancreas results in pancreatic cancer and diabetes mellitus. Pancreatic cancer generally arises from pancreatic ducts when tumor suppressor genes such as DPC4, P16, and P53, and the oncogene K-ras, are mutated (Hruban et al., 2001; Pour et al., 1979) . The cancerous cells express multiple cell-type markers, for example, cytokeratins, insulin, and glucagon (Haglund et al., 1989; Kim et al., 1990) . Type I diabetes arises when the endocrine pancreas, and specifically b cells, are destroyed by autoimmune attack (Mathis et al., 2001; Tisch and McDevitt, 1996) . Although administration of exogenous insulin is sufficient to stabilize blood glucose in type I diabetic patients, a cure depends on replacement of functional b cells. Unfortunately, transplanted islets suffer from immunorejection and/or a recurrence of the underlying antiislet immunity. The scarcity of donor islet material makes repeated transplantation impractical. Therefore, we need to know how functional islets can be produced, which requires one to understand their lineage and development.
Pancreatic lineage during embryogenesis
Mouse pancreas development begins at embryonic day 8.5 (E8.5; Green et al., 1992) . At this stage, interactions between the endoderm and surrounding mesoderm induce a group of endodermal cells near the mid-foregut junction Fig. 2 . A cartoon displaying the structure of mouse pancreas. Three acini are shown draining into a small intercalary duct, which empties into a larger intralobular duct, shown in cross-section with its supporting fibrous matrix. An islet is shown embedded in the exocrine tissue and in close association with the duct system. to adopt a pancreatic fate (Deutsch et al., 2001; Hebrok et al., 1998; Kim et al., 1997; Lammert et al., 2001; Wells and Melton, 2000) . Later, this specified endoderm expands to form the pancreas rudiment. This coincides with the expression of several genes in this endodermal domain. The earliest detected marker, the homeogene Pdx1, is detected in a broad domain in the prospective pancreatic region at E8.5 (Guz et al., 1995) . Gene knockout experiments demonstrated that its function is required for the development of all pancreatic cells (Jonsson et al., 1994; Offield et al., 1996) . In addition, two basic helix-loop-helix genes, Ngn3 and P48, detected in scattered cells within the early pancreatic region (Sommer et al., 1996) , are required for endocrine islet (Apelqvist et al., 1999; Gradwohl et al., 2000) or exocrine and some portion of the endocrine pancreas development (Kawaguchi et al., 2002) . These results suggest these gene products as candidate markers for pancreatic cell lineages.
Endoderm gives rise to all pancreatic tissues
In vitro tissue culture and in vivo transplantation demonstrate that endoderm can give rise to all pancreatic tissues. When genetically labeled prepancreatic endoderm epithelium is cultured with unmarked mesenchyme, the endoderm forms acini, islets, and ducts, but no mesodermal contribution is found (Percival and Slack, 1999) . When neural crest cells from quail were transplanted into chick embryos, it was found that endocrine islet cells in the chimera derive only from the chick tissues (Le Douarin, 1978) . When E9 rat embryos (equivalent to E8 in mouse, just as pancreas is emerging) were cultured in vitro, endocrine islet cells were generated regardless of whether the neural crest had first been removed (Pictet et al., 1976 ). These results demonstrate that the mesenchyme does not contribute to pancreatic cells and that neural crest cells do not contribute to endocrine islets during embryogenesis. They further demonstrate that cells within the endodermal rudiment contain progenitors that give rise to all three types of pancreatic tissues (Edlund, 2001) .
The endoderm as a tissue is multipotent
Gittes et al., 1996 cultured isolated pancreatic rudiments under various conditions. They found that when isolated pancreatic epithelium from E11 embryos was cultured with synchronous pancreatic mesenchyme, all three types of pancreatic tissues (endocrine, exocrine, and duct) were generated. When the epithelium alone was transplanted under the kidney capsule, only islet cells were produced, whereas when the epithelium was cultured alone on matrigel, only duct-like structures were formed. These results suggest that different pancreatic lineages require different mesenchymal factors for their development. It also suggests that endocrine islets can be generated without the presence of pancreatic ducts. Although it is potentially possible that the in vitro conditions used might cause cell transdifferentiation from pancreatic duct to other cell fates, this finding is consistent with a hypothesis that the lineages for the pancreatic duct and endocrine tissues have separated by E11. In other words, two separate cell populations or progenitors pools are set aside before E11, one producing ducts and the other producing endocrine tissue.
Individual cells within the early pancreatic rudiment are multipotent progenitors for acinar and islet cells
In vitro studies suggest that common progenitors for endocrine islet and exocrine acinar cells exist during early pancreas formation. Fishman and Melton (2002) isolated E11.5 pancreatic rudiments and labeled single cells in vitro using a replication incompetent virus. They demonstrated that a single infected pancreatic progenitor cell is able to give rise to both endocrine and exocrine cells, suggesting that multipotent progenitor cells for both endocrine and exocrine tissues are present in early pancreas rudiments. Because pancreatic duct cells were not examined in this study, it is not known whether these progenitors also give rise to duct cells.
The progenitor cells for the islets/acini and pancreatic ducts express Pdx1 in different temporal patterns
The Cre/LoxP method demonstrated that all three types of pancreatic cells derive from PDX1 1 progenitors (Gannon et al., 2000; Gu et al., 2002) . Selective labeling of cells that express Pdx1 at a particular developmental stage by inducible recombinase demonstrated that progenitors which express Pdx1 at different developmental stages have different fates (Gu et al., 2002) . Cells expressing Pdx1 between E9.5 and E11.5 give rise to pancreatic duct, endocrine islet, and exocrine acinar cells. Cells expressing Pdx1 at E8.5, or at E12.5 or thereafter, only give rise to exocrine acini or endocrine islets. Stated otherwise, the duct progenitors express detectable PDX1 only around E10.5, whereas the endocrine and exocrine progenitors express PDX1 throughout embryogenesis. This suggests that the lineages for pancreatic duct and the rest of the pancreatic tissues must separate before E12.5. Unfortunately, this possibility cannot be presently addressed by directly marking the duct progenitors, because no known marker specifically labels progenitors of the pancreatic ducts (Githens, 1994) .
NGN31 cells are endocrine progenitors but are not stem cells
Using an Ngn3 or a pancreatic polypeptide promoter to drive expression of Cre recombinase, it was demonstrated that NGN31 progenitors give rise to all endocrine islet cells, and that the b cell progenitor is also PP1 (Gu et al., 2002; Herrera, 2000) . When NGN31 cells were labeled and their progeny followed at different developmental stages using the Cre-ERe/LoxP system, no instances were found in which the progeny of a NGN31 cell maintains Ngn3 expression. This result suggests that the NGN31 cells do not renew themselves. Therefore, they are transient progeni-tors but not stem cells (Gu et al., 2002) . The NGN31 cells detected throughout embryogenesis must be generated from NGN32 cells. Due to the inability of labeling one NGN31 cell and identifying all of its progeny in the adult, it is not known whether each particular NGN31 cell is multipotent or unipotent, i.e. whether a single NGN31 cell gives rise to all four type of endocrine cells.
The primitive pancreatic 'duct' seen during embryogenesis is a heterogeneous population
Following the progeny of NGN31 cells using Cre/LoxP through various developmental stages revealed that some of the structures seen in the embryonic pancreas and previously described as 'pancreatic ducts' contain mostly endocrine progenitors. The cells within these 'duct-like structures' later coalesce to form mature islets (Gu et al., 2002) . Therefore, another population that does not contain progeny of NGN31 cells must give rise to the adult duct system. These findings point to the heterogeneity of the embryonic ductal structures and suggests that the definition of the generic term 'pancreatic duct' needs revisiting. We propose that 'pancreatic duct' be used to refer only to the duct structures in the mature pancreas, and that 'primitive pancreatic duct' or 'duct-like structures' be used to refer to the tubular structures observed during embryogenesis which may not form ducts in adults.
A model for pancreatic cell lineage during ontogeny
Current lineage analysis data is consistent with two models (Fig. 3, model I and model II) . In the simplest model, at E8.5, an intracellular program or an extracellular signal allows Pdx1 expression in endocrine/exocrine progenitors, which continue to express Pdx1 throughout embryogenesis. In contrast, the predetermined duct progenitors do not begin to express Pdx1 until E9.5 and only do so until E12.5. In an alternative interpretation of the data, the lineage of the duct and endocrine/exocrine progenitors do not separate until E12.5. In this scenario, cells within the prospective pancreatic region all have the same potential before E8.5. When cells within the region start to express Pdx1, those that first express Pdx1 give rise to mature endocrine or exocrine tissue, but not ducts. Of cells that begin to express Pdx1 between E9.5 and E12.5, conversely, some will form pancreatic duct and others will form endocrine or exocrine cells. In both models, the duct and endocrine/ exocrine progenitors diverge before E12.5, and in both scenarios, the initiation of Ngn3 expression within some PDX1 1 cells establishes them as endocrine progenitors.
Pancreatic lineage during postnatal growth and during regeneration
Like most vertebrate organs, the mouse pancreas increases in size as animals grow to reach adulthood (Slack, 1995) . In adult mice, cells in the pancreas turn over at a half-life of about 2 months (Magami et al., 2002; Tsubouchi et al., 1986) . Furthermore, limited yet detectable regenerating ability is observed after physical or chemical injury. These observations suggest that a population of pancreatic cells maintains the ability to generate new cells to allow organ growth and compensate for cell losses.
Cell proliferation during postnatal growth
During early postnatal growth, active mitosis is observed within all three types of functional pancreatic cells (Magami et al., 2002; Muller et al., 1990; Tsubouchi et al., 1986) . This result suggests that part or all of postnatal pancreas growth is a result of the replication of existing mature cells. Although the substantial regenerating ability of the neonatal pancreas suggests the presence of multipotent progenitor cells in the immediately postnatal pancreas (Wang et al., 1996) , their presence had not been directly demonstrated.
6.2. NGN3 1 cells exist in the adult pancreas and they may contribute to mature islet maintenance Mitotic activity is detected in all three types of pancreatic cells in adult mice (Tsubouchi et al., 1986) . In general, the pancreatic ducts display the highest mitotic index. Although Fig. 3 . Two models for the lineage of exocrine, endocrine and duct cells. In both models, the pancreatic duct progenitors express Pdx1 only from E9.5 to E12.5. In Model 1, the duct lineage separates from that of the endocrine/ exocrine cells before E8.5. Endocrine and exocrine cells are distinguished by the presence of Ngn3 expression. In Model 2, the duct and endocrine/ exocrine lineages diverge between E9.5 and E12.5. In the latter model, suppressive or inductive signals are needed to allow for the development of duct fate.
it has been hypothesized that newly derived duct cells contribute to the generation of new islet or acinar cells, no direct evidence for this has been presented. So far, the only direct lineage tracing in normal adult pancreas used CreERe driven by the Ngn3 promoter to label the progeny of Ngn3-expressing cells in adult animals. This demonstrated that there are NGN3 1 cells in the adult pancreas, whose progeny populate islets and may contribute to the maintenance of adult islet mass (Gu et al., 2002) . Because Ngn3 transcript is detectable in hand picked adult islets and Ngn3-cre-ERe only labels cells within the islets of adults (Gu et al., 2002) , it would appear that NGN3 1 islet progenitors reside in the adult islet. Due to the weak promoter activity of Ngn3, the level of Ngn3 or Cre-ERe mRNA in the transgenic animals are very low (as demonstrated by reverse transcriptase polymerase chain reaction (RT-PCR) using islet RNA), thus these transcripts or the corresponding proteins could not be reliably detected by immunohistochemical staining or in situ hybridization. Therefore, the possibility that the Cre-ERe transgene expression does not faithfully copy that of endogenous Ngn3 cannot be excluded.
Additionally, results up to now do not exclude the possibility that a minor population of mature pancreatic duct cells turn on Ngn3 expression and rapidly exit the ducts to contribute to islets. Therefore, gene markers that are specific for pancreatic ducts will be particularly helpful in future studies on lineage.
Unanswered issues
7.1. What is the progenitor (or stem) cell that gives rise to the NGN31 cells?
Many questions regarding the endocrine lineage remain unresolved. Because Ngn3 expression is transient, and NGN31 cells are generated during a broad window from E8.5 to E15.5, a pool of NGN32 cells that give rise to NGN31 progenitors throughout early embryogenesis should exist. The identification of these NGN32 cells remains a priority. Isolation of these cells and investigation of their gene expression profile could identify the molecular events that lead to Ngn3 expression, and might shed light on how these progenitor cells maintain their mitotic activity. In addition, the markers for each endocrine cell type need to be addressed. It is important to identify the specific progenitors for the b cells and to study their development and gene expression pattern in order to reveal the genetic network that controls b cell development.
Do stem cells exist in adults?
The presence of specific progenitors or stem cells responsible for adult islet cell renewal has been a subject of debate over many years. Kinetic analyses of pancreatic endocrine cells during postnatal growth imply that b cells replicate and apoptose, and therefore have a finite lifespan and must be periodically replaced (Finegood et al., 1995; Magami et al., 2002; Montanya et al., 2000; Zajicek et al., 1990) . Renewal of adult endocrine cells could involve replication of existing mature cells (Bouwens, 1998) or neogenesis from a nonendocrine precursor or stem cell . The latter could occur via a relatively undifferentiated stem or progenitor cell, or by transdifferentiation of endocrine cells from a differentiated non-endocrine cell, such as the duct cells (Bouwens, 1998) . It has also been suggested that b cell replication is the primary means of b cell maintenance in the normal adult, with neogenesis required by more severe stresses. It is not known, however, whether hormone-positive cells that are positive for replication markers such as bromodeoxyuridine represent mature functional cells. b Cell neogenesis may also occur postnatally; cell kinetics during early postnatal growth suggest a profound remodeling of the b cell compartment that would seem to require neogenesis to maintain b cell numbers (Finegood et al., 1995) , and similarly cell kinetic analysis in certain models of regeneration suggest that b-cell mitotic activity is insufficient to explain the observed increase in b cell number (Wang et al., 1995) .
Do progenitor cells in mature pancreatic duct contribute to islet neogenesis during regeneration?
Damage to the pancreas, including chemical ablation (Fernandes et al., 1997; Fogli et al., 1999; Muller et al., 1991) , pancreatectomy (Bonner-Weir et al., 1993) , and duct obstruction (Rosenberg, 1998) all increase mitotic activity in the pancreas, especially the sections close to the site of injury. In these models, the pancreatic ducts typically have greater mitotic activity than either acinar or islet cells, and this led to the hypothesis that, during regeneration, duct cells act as progenitors for the generation of new pancreatic cells (Bonner-Weir, 2000; Cornelius et al., 1997; Soria et al., 2000) . In some instances, induction of Pdx-1 expression in ducts is observed (Kritzik et al., 2000; Sharma et al., 1999) , which has led to the suggestion that the embryonic endocrine-cell fate-specification pathway may be reactivated in these models. Nonetheless, the number of 'regenerated' cells is generally very small, and their eventual fate has not been demonstrated.
In vitro culture experiments also offer some support for neogenesis from pancreatic ducts. Isolated adult duct epithelium can give rise to insulin-expressing cells when cultured with fetal mesenchyme (Dudek et al., 1991) , and insulinsecreting cells can be generated by in vitro culture of preparations enriched in ducts from normal human pancreas or non-obese diabetic (NOD) mice (Bonner-Weir et al., 1993 Soria et al., 2000) . These cultured cell lines could reverse diabetes in vivo (Cornelius et al., 1997; Ramiya et al., 2000) . Since these in vitro-derived cells have very low insulin content, and because a lack of good duct markers means that it is unclear whether the starting duct preparations are pure, a clear interpretation of this data is compromised. Current markers label only a subset of duct cells [e.g. carbonic anhydrase (Githens, 1988) ], or also label other tissue types (e.g. cytokeratins). It is unlikely that the issue of ductal contribution to islets, in these in vitro experiments or in in vivo models of regeneration, can be resolved until there are unequivocal markers for duct cells and their progenitors.
Does cell transdifferentiation happen in adult pancreas?
At early embryonic stages, the ventral pancreas and the liver seem to share the same set of progenitors. These cells are specified as liver when they are exposed to FGF signals from the cardiac tissue, while in the absence of the FGF signals, these cells become pancreas (Deutsch et al., 2001) . Similar fate conversion is also observed in adult animals. For example, when rats are fed a copper deficient diet, hepatocytes are observed in the pancreas (Rao and Reddy, 1995) , and under some pathological conditions, pancreatic cells can be observed in the liver (Wolf et al., 1990) . Shen et al. (2000) studied the mechanism of this transdifferentiation in detail and demonstrated that the activation of a single transcription factor by dexamethasone, C/ EBPb, is sufficient to convert exocrine cells to liver cells. These results demonstrated that mature pancreatic or liver cells do maintain plasticity. It would therefore be interesting to directly label each type of cell and determine whether they interconvert in vivo, either under normal growth conditions or in regenerating models.
Do stem cells from other tissues contribute to pancreas development?
One of the most exciting areas of developmental biology in the past 5 years has been the demonstration of the plasticity of different stem cell populations (Blau et al., 2001; Goodell et al., 2001; Orkin, 2000; Orkin and Zon, 2002; Temple, 2001; Wulf et al., 2001) . By transplanting isolated hematopoietic stem cells into another animal, it was shown that these cells contribute to multiple tissues, including muscle (Ferrari et al., 1998) , endothelial cells (Shi et al., 1998) , liver (Alison et al., 2000) , and neuralectodermal cells (Eglitis and Mezey, 1997) . Similarly, isolated neural stem cells can contribute to blood lineages (Bjornson et al., 1999) . Unfortunately, the mechanisms underlying these remarkable results have not been found. There are at least three possible explanations: (1) a universal stem cell exists in the adult that can give rise to all tissues (Blau et al., 2001) ; (2) given the right conditions, the cell fate of existing stem cells can be redirected; (3) the observed plasticity could be an artifact of uncontrolled fusion of the donor cells with host tissue (Terada et al., 2002; Ying et al., 2002) . In any case, no definitive evidence has been obtained to suggest that during embryogenesis, stem cells from one germ layer are able to contribute to mature tissues of another germ layer.
For pancreas development, the existing evidence summarized above suggests that pancreatic tissue derives exclusively from endoderm. Yet these lineage experiments cannot exclude the possibility that PDX1-negative cells from other germ layers migrate into the endoderm, turn on Pdx1 or Ngn3 expression, and then contribute to pancreatic tissues. Further experiments, such as grafting labeled hematopoietic stem cells (which are mesodermal) or neural stem cells (ectodermal) to unlabeled individuals, may be able to address this possibility. A larger range of cell-type specificmarkers would assist in exploring the possible heterogeneity of the stem cell population (He et al., 2001; Kalyani et al., 1997) , to determine whether the hematopoietic or neural stem cells isolated by cell surface markers represent a homogenous population. If not, different subsets of the stem cell populations could be labeled (Orkin and Zon, 2002) to unequivocally determine whether a specific subset of these cells contributes to pancreas renewal. A combination of the ability to identify specific cell lineages, and to identify the genes active within each lineage using DNA microarray analysis, should allow one to isolate these cells and perhaps direct them to a different fate.
